Sotera Health Appoints Alton Shader as New CEO, Details Substantial Executive Compensation Packages
SHC sits 42% above its 52-week low of $10.795 on elevated volume (2.8× avg).
Summary
Sotera Health appoints Alton Shader as CEO, with Michael B. Petras, Jr. becoming Executive Chairman, detailing comprehensive compensation packages for both roles.
Key Events · Executive and Board Changes · SHC
-
New CEO Appointed
Alton Shader, previously CEO of Viant Medical, has been appointed Chief Executive Officer and a Class II director, effective May 26, 2026. He brings over 20 years of medical industry experience.
-
Executive Chairman Transition
Michael B. Petras, Jr. will transition from CEO and Chairman to Executive Chairman of the Board, remaining actively involved in investor relations, commercial, and litigation strategy.
-
New CEO Compensation Detailed
Mr. Shader's compensation includes a $1,000,000 annual base salary, 110% target bonus, a $6,000,000 sign-on RSU grant, and initial annual equity awards totaling $8,125,000 for 2026, with future annual long-term incentive awards targeted at $6,500,000.
-
Executive Chairman Compensation Detailed
Mr. Petras, as Executive Chairman, will receive an annual base salary of $900,000, a 110% target bonus, and will be eligible for annual long-term incentive awards with a target grant date fair value of $5,000,000 starting in 2027.
Analysis · SHC · Industrial Applications And Services
Sotera Health has announced a significant leadership transition, appointing Alton Shader, formerly CEO of Viant Medical, as its new Chief Executive Officer. This move is part of a planned succession, with former CEO Michael B. Petras, Jr. transitioning to Executive Chairman. The filing provides extensive details on the compensation packages for both executives, including a substantial $6 million sign-on equity award for Mr. Shader and significant annual long-term incentive awards for both. This detailed disclosure is crucial for investors to understand the company's executive incentives and the financial implications of the leadership change, which appears to be a smooth, strategically planned transition aimed at leveraging new leadership while retaining experienced guidance.
At the time of this filing, SHC was trading at $15.33 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $10.80 to $19.85. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.